Core Scientific, Inc. CORZ Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $354.74M-13.7% | $319.02M-37.5% | $334.18M-40.1% | $348.43M-39.4% | $410.91M-26.8% | ||
| $294.95M-17.9% | $281.12M-27.8% | $312.28M-22.3% | $330.59M-18.2% | $359.27M-8.3% | ||
| $59.79M+15.8% | $37.9M-68.7% | $21.91M-85.9% | $17.85M-89.6% | $51.64M-69.5% | ||
| 16.9%+4.3pp | 11.9%-11.8pp | 6.6%-21.3pp | 5.1%-24.6pp | 12.6%-17.6pp | ||
| $171.78M+33.1% | $159.22M+40.0% | $183.62M+58.7% | $154.61M+51.0% | $129.05M+31.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $3.06M+103% | -$4.84M+95.8% | -$20.8M+79.2% | ||
| —— | —— | -$601.36M+52.6% | -$926.15M-4.8% | -$827.13M-807% | ||
| -$23.31M-5,787% | -$9.68M-130% | -$7.25M-31.8% | -$4.83M+9.4% | -$396K+93.1% | ||
| $978K+14.0% | $583K-32.1% | $863K+5.2% | $872K+9.0% | $858K+9.3% | ||
| —— | —— | -$798.36M+40.5% | -$1.11B-19.2% | -$1.07B-2,928% | ||
| -$3.36+38.8% | -$0.88+85.3% | $0.23+104% | -$0.48+89.9% | -$5.49-2,212% | ||
| 1.3B+17.2% | 1.3B+30.6% | 1.3B+10.8% | 1.2B+0.5% | 1.1B-23.3% | ||
| 1.3B+22.6% | 1.3B+32.6% | 1.2B+11.6% | 1.2B+0.8% | 1B-23.9% | ||
| -$27.47M-124% | -$31.6M-1,881% | $29.26M+3,804% | $18.1M+3,199% | -$12.28M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $588.07M-48.6% | $921.73M+25.2% | $807.81M+1,444% | ||
| —— | —— | $3.06M+103% | -$4.84M+95.8% | -$20.8M+79.2% | ||
| —— | —— | —— | —— | $4.22M+250% | ||
| —— | —— | —— | —— | $21.97M+540% | ||
| -$23.31M-5,787% | -$9.68M-130% | -$7.25M-31.8% | -$4.83M+9.4% | -$396K+93.1% | ||
| $30.95M+284% | $10.78M+188% | -$18.25M-124% | -$17.17M-120% | -$16.83M-118% | ||
| -$36.47M-344% | -$17.4M-1,026% | $71.69M-1.1% | $38.35M-57.7% | $14.94M-87.6% | ||
| $912.48M+17.6% | -$63.1M-108% | $556.88M+155% | $744.43M+3,499% | $776.2M+7,131% | ||
| -$1.04B-582% | -$740.75M-678% | -$496.22M— | -$273.1M— | -$152.24M— | ||
| $573.17M+2,457% | $278.25M+549% | $138.99M+174% | $12.92M-74.4% | -$24.32M-136% | ||
| -$321K-114% | -$468K-169% | $113K— | $2.46M— | $2.27M— | ||
| —— | —— | —— | —— | $153.59M+400% | ||
| -$447.59M-219% | -$181.12M-528% | -$115.28M-353% | -$86.71M-223% | -$140.39M-187% | ||
| -126.2%-92.0pp | -56.8%-51.1pp | -34.5%-42.7pp | -24.9%-37.1pp | -34.2%-63.0pp | ||
| -$513.42M-110% | -$250.03M-76.0% | -$196.14M-170% | -$179.93M-313% | -$244.33M-532% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Core Scientific, Inc.'s revenue?
- Core Scientific, Inc. (CORZ) generated $354.7M in revenue over the trailing twelve months, down 13.7% year over year.
- Is Core Scientific, Inc. profitable?
- Core Scientific, Inc. is not currently profitable: it reported a net loss of $854.4M over the trailing twelve months, a -238.9% net margin.
- What are Core Scientific, Inc.'s profit margins?
- Gross margin is 16.9% and operating margin is -144.7%, with a -238.9% net margin.
- What is Core Scientific, Inc.'s earnings per share?
- Core Scientific, Inc.'s diluted EPS over the trailing twelve months is $-3.18.
- Where does Core Scientific, Inc.'s income statement data come from?
- Every line is extracted from Core Scientific, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
